MXPA04002510A - Combinacion de opioides selectos con antagonistas de muscarina para tratamiento de incontinencia urinaria. - Google Patents
Combinacion de opioides selectos con antagonistas de muscarina para tratamiento de incontinencia urinaria.Info
- Publication number
- MXPA04002510A MXPA04002510A MXPA04002510A MXPA04002510A MXPA04002510A MX PA04002510 A MXPA04002510 A MX PA04002510A MX PA04002510 A MXPA04002510 A MX PA04002510A MX PA04002510 A MXPA04002510 A MX PA04002510A MX PA04002510 A MXPA04002510 A MX PA04002510A
- Authority
- MX
- Mexico
- Prior art keywords
- urinary incontinence
- combination
- treating urinary
- opioids
- muscarine antagonists
- Prior art date
Links
- 206010046543 Urinary incontinence Diseases 0.000 title abstract 3
- 229940005483 opioid analgesics Drugs 0.000 title abstract 2
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 206010027566 Micturition urgency Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000001022 anti-muscarinic effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10146275A DE10146275A1 (de) | 2001-09-18 | 2001-09-18 | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
| PCT/EP2002/010460 WO2003024444A1 (de) | 2001-09-18 | 2002-09-18 | Kombination ausgewählter opioide mit muscarin-antagonisten zur therapie der harninkontinenz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04002510A true MXPA04002510A (es) | 2004-05-31 |
Family
ID=7699618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04002510A MXPA04002510A (es) | 2001-09-18 | 2002-09-18 | Combinacion de opioides selectos con antagonistas de muscarina para tratamiento de incontinencia urinaria. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20040242617A1 (https=) |
| EP (1) | EP1429754B1 (https=) |
| JP (1) | JP4511176B2 (https=) |
| KR (1) | KR100891438B1 (https=) |
| CN (1) | CN100384413C (https=) |
| AT (1) | ATE383854T1 (https=) |
| AU (1) | AU2002342707B2 (https=) |
| BR (1) | BR0212714A (https=) |
| CA (1) | CA2460655C (https=) |
| DE (2) | DE10146275A1 (https=) |
| EC (1) | ECSP045025A (https=) |
| ES (1) | ES2299608T3 (https=) |
| HU (1) | HUP0401485A3 (https=) |
| IL (2) | IL160894A0 (https=) |
| MX (1) | MXPA04002510A (https=) |
| NO (1) | NO333016B1 (https=) |
| NZ (1) | NZ531777A (https=) |
| PL (1) | PL209272B1 (https=) |
| RU (1) | RU2305562C2 (https=) |
| WO (1) | WO2003024444A1 (https=) |
| ZA (1) | ZA200402853B (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10146275A1 (de) | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
| DE10224108A1 (de) * | 2002-05-29 | 2004-01-29 | Grünenthal GmbH | 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung |
| US7410965B2 (en) | 2002-05-29 | 2008-08-12 | Gruenenthal Gmbh | Delayed release pharmaceutical composition containing 1-dimethyl-amino-3-(3-methoxyphenyl)-2-methyl-pentan-3-ol |
| DE10224556A1 (de) * | 2002-05-31 | 2004-01-08 | Grünenthal GmbH | 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen |
| ES2288641T3 (es) * | 2002-12-20 | 2008-01-16 | Dynogen Pharmaceuticals Inc. | Metodo para tratar trastornos indoloros de la vejiga usando moduladores de canales del calcio de la subunidad alfa2-delta. |
| DE602004003172T2 (de) * | 2003-03-21 | 2007-09-27 | Dynogen Pharmaceuticals Inc., Waltham | Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals |
| DE10356362A1 (de) * | 2003-11-28 | 2005-06-23 | Grünenthal GmbH | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen |
| AU2005245403B2 (en) * | 2004-05-14 | 2012-04-19 | Janssen Pharmaceutica N.V. | Carboxamido opioid compounds |
| DE102005009217A1 (de) * | 2005-02-25 | 2006-08-31 | Grünenthal GmbH | Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen |
| US20070032551A1 (en) * | 2005-07-22 | 2007-02-08 | Gruenenthal Gmbh | Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof |
| JP5323480B2 (ja) * | 2005-07-22 | 2013-10-23 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ３−［２−（ジメチルアミノ）メチル−（シクロヘキシ−１−イル）］−フェノールのＨＣｌ多形体 |
| US7884247B2 (en) * | 2005-07-22 | 2011-02-08 | Gruenenthal Gmbh | Salt of dimethylaminomethyl-phenyl-cyclohexane and crystalline forms thereof |
| DE102007022790A1 (de) | 2007-05-11 | 2008-11-20 | Grünenthal GmbH | Axomadol zur Schmerzbehandlung bei Arthrose |
| BRPI0921725A2 (pt) * | 2008-10-30 | 2016-01-05 | Grüenthal GmbH | formas de dosagem potentes do tapentadol |
| WO2011110595A1 (de) | 2010-03-10 | 2011-09-15 | Grünenthal GmbH | Kristalline salze und/oder cokristalle von o-desmethyltramadol |
| CA2798884C (en) | 2010-05-10 | 2016-09-13 | Euro-Celtique S.A. | Manufacturing of active-free granules and tablets comprising the same |
| AU2011252039B2 (en) | 2010-05-10 | 2014-06-12 | Euro-Celtique S.A. | Pharmaceutical compositions comprising hydromorphone and naloxone |
| CN103002881B (zh) | 2010-05-10 | 2015-09-02 | 欧洲凯尔特公司 | 载有活性剂的颗粒与额外活性剂的组合 |
| CN103040828B (zh) * | 2013-01-07 | 2015-12-02 | 常州康普药业有限公司 | 复方地芬诺酯片及其制备方法 |
| WO2015071380A1 (en) | 2013-11-13 | 2015-05-21 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB857194A (en) * | 1957-07-05 | 1960-12-29 | Clinical Products Ltd | Therapeutic agents comprising ion-exchange resins |
| NL127065C (https=) | 1964-04-22 | |||
| US5736577A (en) | 1995-01-31 | 1998-04-07 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
| DE3012837A1 (de) * | 1979-04-10 | 1980-10-30 | Sandoz Ag | Analgetische und myotonolytische praeparate |
| DE3129982A1 (de) * | 1981-07-29 | 1983-02-17 | Jutta 8200 Rosenheim Meyer | "antiallergikum" |
| US5073560A (en) | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
| DE4041559A1 (de) | 1990-12-22 | 1992-06-25 | Boehringer Ingelheim Kg | Neue wirkstoffkombinationen |
| SE9202218D0 (sv) * | 1992-07-22 | 1992-07-22 | Kabi Pharmacia Ab | Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation |
| CN1054850C (zh) * | 1993-07-30 | 2000-07-26 | 德尔塔药物公司 | 用于治疗的哌嗪化合物 |
| DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| DE69631525T2 (de) * | 1995-03-03 | 2004-12-16 | Endo Pharmaceuticals Inc. | Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz |
| DE19525137C2 (de) | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
| DE19609847A1 (de) * | 1996-03-13 | 1997-09-18 | Gruenenthal Gmbh | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| JP2000515525A (ja) | 1996-07-19 | 2000-11-21 | アベーグ，グンナー | 尿と胃腸の疾患の治療におけるｓ（―）―トルテロジン |
| EP1005861B1 (en) * | 1997-04-11 | 2005-06-29 | Nippon Shinyaku Co., Ltd. | Remedies for frequent urination and urinary incontinence |
| PE20010623A1 (es) * | 1999-10-05 | 2001-07-07 | Gruenenthal Chemie | Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria |
| PT1257277E (pt) * | 2000-02-24 | 2005-09-30 | Pharmacia & Upjohn Co Llc | Novas combinacoes de farmacos |
| DE10059412A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
| DE10146275A1 (de) | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
-
2001
- 2001-09-18 DE DE10146275A patent/DE10146275A1/de not_active Withdrawn
-
2002
- 2002-09-18 PL PL369235A patent/PL209272B1/pl unknown
- 2002-09-18 DE DE50211566T patent/DE50211566D1/de not_active Expired - Lifetime
- 2002-09-18 CN CNB028227794A patent/CN100384413C/zh not_active Expired - Fee Related
- 2002-09-18 KR KR1020047004002A patent/KR100891438B1/ko not_active Expired - Fee Related
- 2002-09-18 CA CA2460655A patent/CA2460655C/en not_active Expired - Fee Related
- 2002-09-18 AT AT02779368T patent/ATE383854T1/de active
- 2002-09-18 AU AU2002342707A patent/AU2002342707B2/en not_active Ceased
- 2002-09-18 HU HU0401485A patent/HUP0401485A3/hu unknown
- 2002-09-18 JP JP2003528540A patent/JP4511176B2/ja not_active Expired - Fee Related
- 2002-09-18 EP EP02779368A patent/EP1429754B1/de not_active Expired - Lifetime
- 2002-09-18 ES ES02779368T patent/ES2299608T3/es not_active Expired - Lifetime
- 2002-09-18 MX MXPA04002510A patent/MXPA04002510A/es active IP Right Grant
- 2002-09-18 WO PCT/EP2002/010460 patent/WO2003024444A1/de not_active Ceased
- 2002-09-18 RU RU2004111788/15A patent/RU2305562C2/ru not_active IP Right Cessation
- 2002-09-18 BR BR0212714-8A patent/BR0212714A/pt not_active Application Discontinuation
- 2002-09-18 IL IL16089402A patent/IL160894A0/xx unknown
- 2002-09-18 NZ NZ531777A patent/NZ531777A/en not_active IP Right Cessation
-
2004
- 2004-03-12 NO NO20041059A patent/NO333016B1/no not_active IP Right Cessation
- 2004-03-16 IL IL160894A patent/IL160894A/en not_active IP Right Cessation
- 2004-03-17 EC EC2004005025A patent/ECSP045025A/es unknown
- 2004-03-18 US US10/803,187 patent/US20040242617A1/en not_active Abandoned
- 2004-04-15 ZA ZA2004/02853A patent/ZA200402853B/en unknown
-
2011
- 2011-09-23 US US13/242,672 patent/US8946290B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04002510A (es) | Combinacion de opioides selectos con antagonistas de muscarina para tratamiento de incontinencia urinaria. | |
| EA200101156A1 (ru) | ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ | |
| MXPA03007712A (es) | Sales farmaceuticas. | |
| ZA200502247B (en) | Selected CGRP antagonists, method for production and use thereof as medicament. | |
| WO2003039632A3 (en) | A medicament container, a medicament dispensing kit for administering medication and a method for packaging the same | |
| WO2003009838A1 (en) | Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus | |
| CY1108377T1 (el) | Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων | |
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| AU2003290015A1 (en) | Mastitis treatment | |
| WO2001060343A3 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| WO2005089449A3 (en) | Methods for treating alcoholism | |
| ZA200110244B (en) | Novel xanthone compounds, their preparation and use as medicament. | |
| MXPA03006742A (es) | Uso de buprenorfina para la terapia de la incontinencia urinaria. | |
| SE0000303D0 (sv) | Novel compounds | |
| CA2430281A1 (en) | Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence | |
| NO20032411L (no) | Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens | |
| AU2002254930A1 (en) | Novel medicament compositions based on anticholinergic agents and endothelin antagonists | |
| WO2002043712A3 (de) | Verwendung von 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz | |
| SI1458376T1 (sl) | Darifenacin za uporabo pri zdravljenju nuje, ki je posledica prekomerno aktivnega sečnega mehurja | |
| EP1693062A3 (en) | Androgen receptor-dependent gene expression control | |
| AU2502301A (en) | Medicament and combination of compatible medicaments | |
| AU2001241067A1 (en) | Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient | |
| GB0128071D0 (en) | Medicament | |
| MXPA03010920A (es) | Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia. | |
| WO2002049624A3 (de) | Neue arzneimittelkompositionen auf der basis von anticholinergika und dopamin-agonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |